Several studies have also shown that activating compounds that activate the Caspase3-GSDME pathway is effective in cancer therapy, and GSDME has been considered one of the targets for the treatment of different cancer types (eg, melanoma, lung cancer) (60). This evidence concerns the gene GSDME and lung cancer.